We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Bunge Global
BG
$20.2B
| $10.6M | 0.02% |
184,244
+22,122
| +14% | +$1.22M |
|
|
SGI
802
Somnigroup International
SGI
$14B
| $10.6M | 0.02% |
485,836
+2,596
| +0.5% | +$54.3K |
|
803
Wintrust Financial
WTFC
$10.9B
| $10.6M | 0.02% |
148,818
+716
| +0.5% | +$47.7K |
|
|
PCH
804
DELISTED
PotlatchDeltic
PCH
| $10.5M | 0.02% |
243,580
+11,906
| +5% | +$508K |
|
805
Cathay General Bancorp
CATY
$4.27B
| $10.5M | 0.02% |
276,984
+2,631
| +1% | +$96.2K |
|
806
Valvoline
VVV
$4.95B
| $10.5M | 0.02% |
492,031
+3,442
| +0.7% | +$75.9K |
|
807
Independent Bank
INDB
$4.05B
| $10.5M | 0.02% |
126,324
+7,127
| +6% | +$583K |
|
|
STL
808
DELISTED
Sterling Bancorp
STL
| $10.5M | 0.02% |
498,213
-20,561
| -4% | -$419K |
|
809
CVB Financial
CVBF
$4.03B
| $10.5M | 0.02% |
485,311
+35,885
| +8% | +$760K |
|
|
LOGM
810
DELISTED
LogMein, Inc.
LOGM
| $10.5M | 0.02% |
121,924
+2,809
| +2% | +$208K |
|
|
UMPQ
811
DELISTED
Umpqua Holdings Corp
UMPQ
| $10.4M | 0.02% |
589,999
-551
| -0.1% | -$9.12K |
|
|
COHR
812
DELISTED
Coherent Inc
COHR
| $10.4M | 0.02% |
62,693
+3,424
| +6% | +$530K |
|
|
AXE
813
DELISTED
Anixter International Inc
AXE
| $10.4M | 0.02% |
113,112
+8,674
| +8% | +$703K |
|
814
First Solar
FSLR
$25B
| $10.4M | 0.02% |
185,827
+705
| +0.4% | +$38.7K |
|
815
Affiliated Managers Group
AMG
$10.1B
| $10.4M | 0.02% |
122,371
+38,307
| +46% | +$3.14M |
|
816
Insperity
NSP
$2.05B
| $10.3M | 0.02% |
120,272
-4,200
| -3% | -$365K |
|
817
Elanco Animal Health
ELAN
$12.8B
| $10.3M | 0.02% |
349,368
+6,238
| +2% | +$170K |
|
818
Brighthouse Financial
BHF
$3.55B
| $10.3M | 0.02% |
261,960
-2,718
| -1% | -$107K |
|
|
CADE
819
DELISTED
Cadence Bank
CADE
| $10.3M | 0.02% |
327,020
+7,338
| +2% | +$227K |
|
|
SVC
820
Service Properties Trust
SVC
$1.02B
| $10.3M | 0.02% |
84,437
+2,469
| +3% | +$301K |
|
821
UMB Financial
UMBF
$11.2B
| $10.3M | 0.02% |
149,648
-4,415
| -3% | -$293K |
|
822
NovoCure
NVCR
$1.78B
| $10.2M | 0.02% |
121,387
+6,903
| +6% | +$557K |
|
823
Viasat
VSAT
$11.2B
| $10.2M | 0.02% |
139,686
+113
| +0.1% | +$8.08K |
|
824
Trade Desk
TTD
$8.6B
| $10.2M | 0.02% |
393,500
+12,090
| +3% | +$272K |
|
825
Flowers Foods
FLO
$1.53B
| $10.2M | 0.02% |
466,987
-15,261
| -3% | -$331K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.